发明申请
US20120208755A1 Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers 审中-公开
组合物,装置及其使用方法用于治疗癌症

Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
摘要:
The use of GLP-1 receptor agonists, such as glucagon-like peptide-1 (GLP-1) or exenatide, for the treatment of cancer is described. The GLP-1 receptor agonists are typically delivered using an implanted osmotic delivery device that provides for continuous delivery of the GLP-1 receptor agonist for at least one month. Additional beneficial agents, such as anticancer agents, can also be administered.
公开/授权文献
信息查询
0/0